Clinical context
Visual acuity alone is insufficient when judging corneal disease or surgery. Topography and tomography, surface regularity, biomechanics, endothelial cell density, quality of vision and stability all matter. After refractive procedures, epithelial healing, dry eye, haze, ectasia and the need for enhancement should be assessed separately.
What was studied
The investigators evaluated a posterior-chamber implantable phakic contact lens, or IPCL, for myopia and myopic astigmatism. This retrospective analysis included 714 eyes of 430 patients who completed at least 24 months of follow-up; mean age was 26.4 ± 4.9 years. Uncorrected and corrected distance acuity, manifest refraction, intraocular pressure, vault and endothelial cell density were assessed before surgery and at 1, 6, 12 and 24 months. These outcomes address visual performance, predictability, stability and recorded complications, but the study had no concurrent control group.
How the evidence was produced
A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.
How to interpret the result
The series shows two-year predictability in young patients with moderate-to-high myopia. Accurate vision and refraction do not establish superiority over EVO ICL or corneal laser surgery because neither was compared. Rotation matters for toric lenses because it can restore cylinder and lead to another procedure. Even a low cataract rate matters in young patients.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
The study may refine technique selection and informed discussion, but its conclusions depend on baseline corneal shape, stromal thickness, equipment, nomogram and surgeon experience. Applicability requires comparison of these factors and attention to variability, uncommon complications and follow-up duration rather than mean values alone.
Limitations
Retrospective selection and the requirement for two-year follow-up may omit unfavorable or lost cases. Some patients contributed both eyes, and the abstract does not say how within-person correlation was handled. Without a control group, comparative effectiveness and harms remain unknown. Two years cannot characterize late cataract, chronic vault effects, endothelial loss or glaucoma. Verify baseline refraction, IPCL models and sizing, toric proportion, rotation criteria, vault and endothelial distributions, attrition, reoperations, conflicts and analytical independence in the full paper.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.